📊Executive Summary

Bruker Corporation is experiencing a positive shift in order momentum, particularly in semiconductor metrology and overseas markets, which is helping to offset declines in U.S. academic funding. The company is on track for three consecutive quarters with a book-to-bill ratio above 1.0, indicating strong demand. Despite challenges in the U.S. market, Bruker anticipates organic revenue growth resuming in Q2 2026, driven by AI-related demand and capacity expansion in semiconductor-related orders. The company views China as a long-term growth opportunity despite local competition. The article highlights the importance of monitoring order performance and funding timelines for procurement strategies....